OCA.NZ
Oceania Healthcare Limited [OCA.NZ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
OCA.NZ Stock Summary
Top 10 Correlated ETFs
OCA.NZ
Top 10 Correlated Stocks
OCA.NZ
In the News
OCA.NZ Financial details
Company Rating
Buy
Market Cap
463.46M
Income
59.1M
Revenue
387.12M
Book val./share
1.41
Cash/share
0.01
Dividend
0.01
Dividend %
1.73%
Employees
2.9K
Optionable
No
Shortable
Yes
Earnings
22 May 2024
P/E
34.73
Forward P/E
-
PEG
-58.11
P/S
2.2
P/B
0.56
P/C
61
P/FCF
-9.85
Quick Ratio
0.11
Current Ratio
0.22
Debt / Equity
0.61
LT Debt / Equity
0.61
-
-
EPS (TTM)
0.08
EPS next Y
-
EPS next Q
-
EPS this Y
-74.71%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-21.75%
Revenue last 5Y
5.74%
Revenue Q/Q
95.03%
EPS Q/Q
100%
-
-
-
-
SMA20
1.61%
SMA50
-11.27%
SMA100
-10%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
2%
ROC
0.02%
Gross Margin
100%
Oper. Margin
14%
Profit Margin
6%
Payout
141%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.55-0.84
52W High
-
52W Low
-
RSI
43.91
Rel Volume
0.14
Avg Volume
1.39M
Volume
192.89K
Perf Week
-7.58%
Perf Month
-3.17%
Perf Quarter
-12.86%
Perf Half Y
-15.28%
-
-
-
-
Beta
0.678
-
-
Volatility
0.02%, 0.02%
Prev Close
1.67%
Price
0.61
Change
1.67%
OCA.NZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-05-31 | 2020-05-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.31 | 0.32 | 0.34 | 0.33 | 0.35 | |
| Net income per share | 0.08 | -0.02 | 0.17 | 0.09 | 0.02 | |
| Operating cash flow per share | 0.15 | 0.16 | 0.15 | 0.15 | 0.1 | |
| Free cash flow per share | 0.03 | 0.1 | 0.1 | 0.07 | 0.02 | |
| Cash per share | 0.04 | 0.03 | 0.13 | 0.01 | 0.01 | |
| Book value per share | 1.01 | 0.97 | 1.34 | 1.35 | 1.35 | |
| Tangible book value per share | 0.99 | 0.96 | 1.32 | 1.33 | 1.34 | |
| Share holders equity per share | 1.01 | 0.97 | 1.34 | 1.35 | 1.35 | |
| Interest debt per share | 0.45 | 0.63 | 0.55 | 0.62 | 0.86 | |
| Market cap | 634.59M | 549.64M | 795.57M | 740.67M | 522.19M | |
| Enterprise value | 881.98M | 870.47M | 1.05B | 1.12B | 1.07B | |
| P/E ratio | 13.99 | -40.29 | 7.74 | 12.12 | 33.8 | |
| Price to sales ratio | 3.39 | 2.84 | 3.78 | 3.2 | 2.11 | |
| POCF ratio | 7.1 | 5.53 | 8.29 | 7.02 | 7.44 | |
| PFCF ratio | 38.63 | 9.33 | 13.31 | 15.04 | 34.71 | |
| P/B Ratio | 1.04 | 0.92 | 0.95 | 0.78 | 0.54 | |
| PTB ratio | 1.04 | 0.92 | 0.95 | 0.78 | 0.54 | |
| EV to sales | 4.72 | 4.5 | 5.01 | 4.85 | 4.34 | |
| Enterprise value over EBITDA | 14.82 | -124.14 | 86.37 | 12.59 | 20.11 | |
| EV to operating cash flow | 9.87 | 8.76 | 10.99 | 10.62 | 15.29 | |
| EV to free cash flow | 53.69 | 14.77 | 17.64 | 22.77 | 71.32 | |
| Earnings yield | 0.07 | -0.02 | 0.13 | 0.08 | 0.03 | |
| Free cash flow yield | 0.03 | 0.11 | 0.08 | 0.07 | 0.03 | |
| Debt to equity | 0.44 | 0.63 | 0.4 | 0.45 | 0.62 | |
| Debt to assets | 0.19 | 0.24 | 0.18 | 0.2 | 0.24 | |
| Net debt to EBITDA | 4.16 | -45.75 | 21.21 | 4.27 | 10.32 | |
| Current ratio | 0.13 | 0.1 | 0.19 | 0.1 | 0.22 | |
| Interest coverage | 16.68 | -4.09 | -0.38 | 7.96 | 2.56 | |
| Income quality | 1.97 | -7.28 | 0.93 | 1.73 | 4.54 | |
| Dividend Yield | 0.04 | 0.04 | 0.01 | 0.03 | 0.04 | |
| Payout ratio | 0.63 | -1.63 | 0.06 | 0.32 | 1.41 | |
| Sales general and administrative to revenue | 0.68 | 0.76 | 0 | 0.69 | 0.67 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0 | 0 | |
| Capex to operating cash flow | -0.82 | -0.41 | -0.38 | -0.53 | -0.79 | |
| Capex to revenue | -0.39 | -0.21 | -0.17 | -0.24 | -0.22 | |
| Capex to depreciation | -7.64 | -2.79 | -2.23 | -3.02 | -3.08 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 1.31 | 0.7 | 2.23 | 1.62 | 0.81 | |
| ROIC | 0.08 | -0.01 | 0 | 0.06 | 0.03 | |
| Return on tangible assets | 0.03 | -0.01 | 0.06 | 0.03 | 0.01 | |
| Graham Net | -1.22 | -1.48 | -1.5 | -1.69 | -2.02 | |
| Working capital | -439.79M | -555.78M | -537.27M | -776.01M | -800.25M | |
| Tangible asset value | 601.21M | 584.38M | 819.81M | 940.24M | 955.54M | |
| Net current asset value | -723.17M | -894.23M | -920.63M | -1.17B | -1.36B | |
| Invested capital | 0.44 | 0.63 | 0.4 | 0.45 | 0.62 | |
| Average receivables | 36.55M | 41.2M | 42.67M | 55.77M | 86.46M | |
| Average payables | 4.95M | 5.99M | 7.58M | 5.67M | 5.92M | |
| Average inventory | 0.5 | 1 | 1 | 1 | 53.84M | |
| Days sales outstanding | 82.32 | 75.83 | 78.21 | 104.93 | 157.22 | |
| Days payables outstanding | 15.44 | 13.3 | 19.7 | 3.87 | 17.8 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 195.85 | |
| Receivables turnover | 4.43 | 4.81 | 4.67 | 3.48 | 2.32 | |
| Payables turnover | 23.65 | 27.44 | 18.53 | 94.24 | 20.5 | |
| Inventory turnover | 144.72M | 160.76M | 172.32M | 192.53M | 1.86 | |
| ROE | 0.07 | -0.02 | 0.12 | 0.06 | 0.02 | |
| Capex per share | -0.12 | -0.07 | -0.06 | -0.08 | -0.08 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
| Metric | History | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.17 | 0.09 | 0.17 | 0.09 | 0.18 | |
| Net income per share | 0.02 | 0 | 0.01 | 0.02 | 0.05 | |
| Operating cash flow per share | 0.04 | 0.03 | 0.05 | 0.03 | 0.07 | |
| Free cash flow per share | -0.01 | 0.05 | 0.03 | 0.02 | 0.03 | |
| Cash per share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Book value per share | 1.35 | 1.34 | 1.34 | 1.41 | 1.41 | |
| Tangible book value per share | 1.34 | 1.33 | 1.33 | 1.4 | 1.4 | |
| Share holders equity per share | 1.35 | 1.34 | 1.34 | 1.41 | 1.41 | |
| Interest debt per share | 0.72 | 0.77 | 0.85 | 0.85 | 0.87 | |
| Market cap | 648.22M | 545.98M | 526.01M | 556.32M | 512.97M | |
| Enterprise value | 1.15B | 1.09B | 1.08B | 1.16B | 1.13B | |
| P/E ratio | 14.47 | 64.23 | 30.94 | 7.91 | 3.65 | |
| Price to sales ratio | 5.31 | 8.67 | 4.21 | 8.24 | 3.9 | |
| POCF ratio | 20.65 | 28.13 | 13.55 | 23.17 | 10.68 | |
| PFCF ratio | -145.5 | 13.83 | 28.34 | 46 | 21.21 | |
| P/B Ratio | 0.67 | 0.57 | 0.55 | 0.55 | 0.5 | |
| PTB ratio | 0.67 | 0.57 | 0.55 | 0.55 | 0.5 | |
| EV to sales | 9.42 | 17.34 | 8.61 | 17.24 | 8.55 | |
| Enterprise value over EBITDA | 139.28 | 292.57 | 143.65 | 287.46 | 218.64 | |
| EV to operating cash flow | 36.65 | 56.26 | 27.75 | 48.46 | 23.44 | |
| EV to free cash flow | -258.21 | 27.67 | 58.03 | 96.2 | 46.54 | |
| Earnings yield | 0.02 | 0 | 0.01 | 0.03 | 0.07 | |
| Free cash flow yield | -0.01 | 0.07 | 0.04 | 0.02 | 0.05 | |
| Debt to equity | 0.52 | 0.58 | 0.62 | 0.61 | 0.61 | |
| Debt to assets | 0.21 | 0.22 | 0.24 | 0.23 | 0.23 | |
| Net debt to EBITDA | 60.79 | 146.28 | 73.49 | 150.01 | 119.01 | |
| Current ratio | 0.1 | 0.23 | 0.22 | 0.19 | 0.13 | |
| Interest coverage | -0.17 | 0 | -0.14 | 0 | -0.5 | |
| Income quality | 2.8 | 9.13 | 9.13 | 1.37 | 1.37 | |
| Dividend Yield | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | |
| Payout ratio | 1.12 | 2.18 | 2.18 | 0.19 | 0.19 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | -1.14 | 1.03 | -0.52 | -0.5 | -0.5 | |
| Capex to revenue | -0.29 | 0.32 | -0.16 | -0.18 | -0.18 | |
| Capex to depreciation | -3.85 | 4.84 | -2.35 | -2.53 | -2.53 | |
| Stock based compensation to revenue | 0 | 0.01 | 0 | 0 | 0 | |
| Graham number | 0.69 | 0.3 | 0.42 | 0.88 | 1.24 | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | 0.01 | 0.01 | |
| Graham Net | -1.99 | -2.09 | -2 | -2.17 | -2.22 | |
| Working capital | -829.25M | -742.31M | -800.25M | -812.97M | -856M | |
| Tangible asset value | 955.53M | 955.54M | 955.54M | 1.01B | 1.01B | |
| Net current asset value | -1.39B | -1.36B | -1.36B | -1.48B | -1.54B | |
| Invested capital | 0.52 | 0.58 | 0.62 | 0.61 | 0.61 | |
| Average receivables | 86.96M | 91.26M | 101.01M | 114M | 121.53M | |
| Average payables | 45.66M | 27.72M | 9.79M | 30.94M | 52.09M | |
| Average inventory | 0 | 0 | 53.84M | 53.84M | -29.38M | |
| Days sales outstanding | 64.09 | 136.58 | 76.62 | 162.08 | 83.1 | |
| Days payables outstanding | 33.36 | 21.05 | 6.99 | 106.15 | 34.5 | |
| Days of inventory on hand | 0 | 0 | 76.91 | 0 | -38.92 | |
| Receivables turnover | 1.4 | 0.66 | 1.17 | 0.56 | 1.08 | |
| Payables turnover | 2.7 | 4.28 | 12.88 | 0.85 | 2.61 | |
| Inventory turnover | 8266402.76B | 0 | 1.17 | 0 | -2.31 | |
| ROE | 0.01 | 0 | 0 | 0.02 | 0.03 | |
| Capex per share | -0.05 | 0.03 | -0.03 | -0.02 | -0.03 |
OCA.NZ Frequently Asked Questions
What is Oceania Healthcare Limited stock symbol ?
Oceania Healthcare Limited is a NZ stock and trading under the symbol OCA.NZ
What is Oceania Healthcare Limited stock quote today ?
Oceania Healthcare Limited stock price is $0.61 today.
Is Oceania Healthcare Limited stock public?
Yes, Oceania Healthcare Limited is a publicly traded company.
Company Profile
- Volume Average 1.39M
- Market Capitalization 463.46M
- Employee 2.9K
- CEO Mr. Brent Pattison BBS, C.A.
- Headquarters Auckland,NZ
- IPO Date 2017-05-04
-
Website
https://www.oceaniahealthcare.co.nz 
Oceania Healthcare Limited, together with its subsidiaries, owns and operates various retirement village and aged care centers in New Zealand. The company operates through three segments: Care Operations, Village Operations, and Other. It provides rest home, hospital, and dementia; independent living and rental properties for retirement villages; and provides support services, which includes administration, marketing, and operations. The company was formerly known as Retirement Care (NZ) Limited and changed its name to Oceania Healthcare Limited in September 2014. Oceania Healthcare Limited was incorporated in 2005 and is based in Auckland, New Zealand.
